Amylyx Pharmaceuticals (AMLX) Amortizatization of Intangibles (2021 - 2026)

Amylyx Pharmaceuticals' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $609000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 64.24% year-over-year to $609000.0; the TTM figure through Mar 2026 stood at $4.4 million (down 50.63% YoY), while the FY2025 annual figure was $5.5 million, down 43.93% from the prior year.
• Amortizatization of Intangibles was $609000.0 for Q1 2026 at Amylyx Pharmaceuticals, down from $1.1 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q2 2024 to a low of -$2000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $1.8 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 145250.0% in 2023, then slumped 64.24% in 2026.
• A 5-year view of Amortizatization of Intangibles shows it stood at $1.9 million in 2022, then soared by 38.28% to $2.6 million in 2023, then tumbled by 30.37% to $1.8 million in 2024, then tumbled by 40.98% to $1.1 million in 2025, then tumbled by 42.38% to $609000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $609000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.